Bringing the fundamentals into focus…
Back to Enliven Therapeutics, Inc.
How Enliven Therapeutics, Inc. stacks up
ELVN · against 308 other Healthcare companies of similar size
Overall
44/ 100
Below the middle of the pack.
Ranked #208 of 309 · scores higher than 30% of peers
Bars: peers in each 10-point band of the overall score46 peers with an overall score of 40–49, including ELVN · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around ELVN| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 2 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 4 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 5 | 2.29T KRW (≈$1.6B) | 88 | 83 | 90 | 96 | 0 / 2 | |
| 208 | 15.4B HKD (≈$2.0B) | 44 | 82 | 28 | 2 / 2 | ||
| 208 | 12.8B CNY (≈$1.8B) | 44 | 46 | 4 | 55 | 0 / 2 | |
| 208 | 1.7B USD | 44 | 80 | 22 | 48 | 2 / 2 | |
| 208 | 2.9B USD | 44 | 8 | 65 | 29 | 0 / 2 | |
| 208 | 3.3B USD | 44 | 8 | — | 26 | 0 / 2 | |
| 208 | 6.2B USD | 44 | 8 | 82 | 10 | 0 / 2 | |
| 208 | 4.2B USD | 44 | 8 | 93 | 23 | 1 / 2 | |
| 208 | 1.9B USD | 44 | 8 | 96 | 25 | 1 / 2 | |
| 208 | 2.0B USD | 44 | 8 | 83 | 32 | 1 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score